| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327459 | Gynecologic Oncology | 2005 | 5 Pages |
Abstract
Single-agent capecitabine in patients with recurrent cervical cancer resulted in no objective responses. Although capecitabine is a well-tolerated regimen, as a single agent, it offers minimal benefit in a poor-prognosis cervical cancer population.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Alfred D. Jenkins, Lois M. Ramondetta, Charlotte Sun, Taren Johnston, Judith K. Wolf, Diane C. Bodurka, Jubilee Brown, Edward N. Atkinson, Charles Levenback,